Comprehensive Metabolic Panel Testing Market Size Predicted to Hit USD 16.1 billion by 2032 at 4.8% CAGR, Says AMR

Allied Market Research published a report, titled, "Comprehensive Metabolic Panel Testing Market by Test Type (Proteins, Electrolytes, Kidney Tests, Liver Tests, and Others), Disease Indication (Kidney Diseases, Liver Diseases, Diabetes, and Others), and End User (Hospitals, Diagnostic Laboratories, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2023-2032″. According to the report, the global comprehensive metabolic panel testing industry generated $10.1 billion in 2022 and is anticipated to generate $16.1 billion by 2032, witnessing a CAGR of 4.8% from 2023 to 2032.

𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐃𝐫𝐢𝐯𝐢𝐧𝐠 𝐅𝐚𝐜𝐭𝐨𝐫𝐬 𝐎𝐟 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐌𝐞𝐭𝐚𝐛𝐨𝐥𝐢𝐜 𝐏𝐚𝐧𝐞𝐥 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭?

Rise in prevalence of chronic diseases such as chronic kidney diseases, and diabetes, surge in geriatric population, and increase in advancements in diagnostic technologies are the factors that drive the growth of the global comprehensive metabolic panel testing market. However, lack of awareness about CMP testing in underdeveloped regions restricts market growth. Moreover, the high growth potential in emerging countries and rise in surge in trend towards point-of-care testing presents new opportunities in the coming years.

The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

𝐆𝐞𝐭 𝐅𝐮𝐥𝐥 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭 (𝐈𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠 𝐅𝐮𝐥𝐥 𝐓𝐎𝐂, 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐓𝐚𝐛𝐥𝐞𝐬 & 𝐅𝐢𝐠𝐮𝐫𝐞𝐬, 𝐂𝐡𝐚𝐫𝐭) 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞: https://www.alliedmarketresearch.com/request-sample/A269963

𝐑𝐞𝐜𝐞𝐬𝐬𝐢𝐨𝐧 𝐈𝐦𝐩𝐚𝐜𝐭

• During a recession, individuals and governments might tighten their budgets, leading to reduced healthcare spending. This could affect patients' ability to access and afford comprehensive metabolic panel testing, potentially leading to decreased demand for comprehensive metabolic panel testing products.
• However, the surge in prevalence of chronic diseases and rise in technological advancements. This could boost the need for comprehensive metabolic panel testing that is experiencing a moderately positive impact from the global recession.

𝐓𝐨𝐩 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐨𝐟 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐌𝐞𝐭𝐚𝐛𝐨𝐥𝐢𝐜 𝐏𝐚𝐧𝐞𝐥 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭

• Quest Diagnostics
• Laboratory Corporation of America Holdings
• F. Hoffmann-La Roche Ltd.
• Blueprint Genetics
• ARUP Laboratories,
• Walk-In Lab, LLC.
• Applied InGENuity Diagnostics
• Scion Lab Services, LLC
• Baptist Health
• My Care Labs

𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐌𝐞𝐭𝐚𝐛𝐨𝐥𝐢𝐜 𝐏𝐚𝐧𝐞𝐥 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐜𝐚𝐧 𝐛𝐞 𝐝𝐨𝐧𝐞 𝐛𝐚𝐬𝐞𝐝 𝐨𝐧 𝐬𝐞𝐯𝐞𝐫𝐚𝐥 𝐟𝐚𝐜𝐭𝐨𝐫𝐬, 𝐢𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠:

By test type, the kidney tests segment held the largest market share in 2022, accounting for more than one-fourth of the global comprehensive metabolic panel testing market revenue, and is estimated to maintain its leadership status throughout the forecast period. This is attributed to kidney diseases such as chronic kidney disease (CKD) which have become more prevalent due to factors such as aging populations, diabetes, and hypertension thereby driving the demand for CMP testing.

By disease indication, the kidney diseases segment held the largest market share in 2022, accounting for more than one-third of the global comprehensive metabolic panel testing market revenue and is estimated to maintain its leadership status throughout the forecast period. This is attributed to emphasis on early detection and proactive management of kidney diseases fuels the demand for routine monitoring through CMP testing.

By end user, the diagnostic laboratories segment accounted for the largest share in 2022, contributing to nearly half of global comprehensive metabolic panel testing market revenue, and is projected to maintain its lead position during the forecast period. This is attributed to their advanced infrastructure, comprehensive testing capabilities, trained personnel, accessibility, high throughput, integration into healthcare networks, technological advancements, and patient-focused services.

By region, North America held the largest market share in terms of revenue in 2022, accounting for more than two-fifths of the global comprehensive metabolic panel testing market revenue and is likely to dominate the market during the forecast period. This is attributed to its well-developed healthcare infrastructure, technological advancements in testing methodologies, and growing emphasis on preventive healthcare practices in North America.

However, the Asia-Pacific region is expected to witness the fastest CAGR of 5.9% from 2023 to 2032. This is attributed to rise in the prevalence of chronic diseases, including diabetes, cardiovascular disorders, and obesity, increase in awareness of the importance of routine health check-ups and preventive healthcare practices is driving the demand for diagnostic services,

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/A269963

𝐎𝐮𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧 𝐏𝐫𝐨𝐯𝐢𝐝𝐞𝐬 𝐘𝐨𝐮 𝐀𝐧𝐬𝐰𝐞𝐫 𝐭𝐨 𝐁𝐞𝐥𝐨𝐰 𝐌𝐞𝐧𝐭𝐢𝐨𝐧𝐞𝐝 𝐐𝐮𝐞𝐬𝐭𝐢𝐨𝐧:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

Region Analysis

• North America
(U.S., Canada, Mexico)
• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐃𝐞𝐭𝐚𝐢𝐥𝐬:

David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.